期刊文献+

NK4蛋白在大肠埃希菌中的表达、纯化、复性及活性测定 被引量:1

Expression,purification,renaturation and activity assay of NK4 in Escherichia coli
下载PDF
导出
摘要 目的在大肠埃希菌(E.coli)中高表达NK4蛋白,经鉴定、纯化、复性后测定其生物学活性。方法采用重组DNA技术对已有质粒pGEX-4T-1-NK4和pBV220-HGFα进行改造,构建质粒pBV220-NK4,并使其转化E.coliBL21(DE3),温控诱导表达目的蛋白NK4。蛋白鉴定采用SDS-PAGE和Western blot;蛋白纯化采用包涵体超声破碎、洗涤和Sephacryl-S200凝胶过滤层析。经梯度稀释复性后,采用MTT法和免疫细胞化学方法检测重组蛋白NK4对人脐静脉内皮细胞(human umbilical vein endothelial cell,HUVEC)ECV304增殖的作用。结果重组质粒pBV220-NK4酶切图谱和序列测定与预期一致。SDS-PAGE显示有相对分子质量49 000的目的蛋白,表达量为30%。Western blot结果证实目的蛋白带有NK4的氨基端,经包涵体洗涤、层析后NK4的纯度为95%。复性后的NK4可抑制ECV304增殖,并抑制ECV304增殖细胞核抗原(proliferating cell nuclearantigen,PCNA)的表达。结论我们建立了NK4的原核高表达体系及纯化制备工艺,所制备的NK4蛋白具有生物学活性,为大规模制备有活性的NK4及深入研究其相关功能奠定了基础。 Objective To construct a recombinant plasmid expressing NK4 gene in Escherichia coli(E.coli) and to obtain purified NK4 protein with bioactivity. Methods The plasmid pBV220-NK4 was constructed by recombinant technology with utilization of the plasmid pBV220-HGFα and pGEX-4T-1-NK4.The plasmid pBV220-NK4 was identified by the restriction analysis and DNA sequencing.Then recombinant plasmid was transformed into E.coli and the recombinant protein was expressed and detected by SDS-PAGE and Western blot.The expressed protein existing in the form of inclusion body was purified by gel filtration chromatography,and then was detected for the activity by MTT method after renaturation.The expression of the proliferating cell nuclear antigen(PCNA) in human umbilical vein endothelial cells(HUVEC) ECV304 incubated with NK4 was measured by immunohistochemical strain.Results SDS-PAGE showed a specific protein band with relative molecular weight of 49 000.The expressed product existed in the form of insoluble inclusion body and contained about 30% of total somatic protein.After renaturation,the expressed NK4 showed an inhibitory action on ECV304 proliferation by MTT and the ratio of inhibition was 30%(P0.01).The expressed NK4 also obviously depressed the expression of PCNA. Conclusions NK4 protein was successfully expresseed in E.coli,which layed the foundation for the study on the structure and function as well as pilot production of NK4.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2011年第1期60-65,共6页 Fudan University Journal of Medical Sciences
基金 山西省科技攻关项目(20080311059-6) 山西医科大学科技创新项目(01200713)
关键词 NK4 原核表达 纯化 活性测定 NK4 prokaryotic expression purification activity assay
  • 相关文献

参考文献14

  • 1Date K,Matsumoto K,Shimura H,et al.HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor[J].FEBS Lett,1997,420(1):1-6.
  • 2Davies G,Mason MD,Martin TA,et al.The HGF/SF antagonist NK4 reverses fibroblast-and HGF-induced prostate tumor growth and angiogenesis in vivo[J].Int J Cancer,2003,106(3):348-354.
  • 3Kuba K,Matsumoto K,Ohnishi K,et al.Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells[J].Biochem Biophys Res Commun,2000,279(3):846-852.
  • 4Du W,Hattori Y,Yamada T,et al.NK4,an antagonist of hepatocyte growth factor (HGF),inhibits growth of multiple myeloma cells:molecular targeting of angiogenic growth factor[J].Blood,2007,109(7):3 042-3 049.
  • 5Kubota T,Taiyoh H,Matsumura A,et al.NK4,an HGF antagonist,prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells[J].Clin Exp Metastasis,2009,26(5):447-456.
  • 6Nakamura T,Sakai K,Nakamura T,et al.Anti-cancer approach with NK4:bivalent action and mechanisms[J].Anticancer Agents Med Chem,2010,10(1):36-46.
  • 7常冰梅,王勇,解军,张悦红,程牛亮,牛勃,胡晓年,向前.表达人肝细胞生长因子突变体——NK4工程菌的发酵工艺研究[J].中国生物制品学杂志,2005,18(2):132-134. 被引量:1
  • 8萨姆布鲁克 弗里奇 曼尼阿蒂斯.分子克隆实验指南[M] 2版[M].北京:科学出版社,1992.16-69.
  • 9杨涛,杨利军,冯仟佳,程牛亮,牛勃.人肝细胞生长因子α原核表达体系的构建及表达[J].中华微生物学和免疫学杂志,2004,24(4):329-329. 被引量:1
  • 10刘宏磊,李希,宋后燕,汤其群.人脂联素球状结构域的表达、纯化和功能鉴定[J].复旦学报(医学版),2006,33(1):97-100. 被引量:2

二级参考文献31

  • 1Nakano Y,Tobe T,Tomita M,et al.Isolation and characterization of GBP28,a novel Gelatin-Binding Protein from human plasma[J].J Biochem,1996,120:803.
  • 2Hu E,Liang P,Spiegelman B M,et al.AdipoQ is a novel;adipose-specific gene dysregulated in obesity[J].J Bio Chem,1996,271:10697.
  • 3Scherer P E,Williamas S,Lodish H F,et al.A novel serum protein similar to C1 q,produced exclusively in adipocytes[J].J Bio Chem,1995,270:26746.
  • 4Maeda K,Okubo K,Matsubara K,et al.eDNA cloning and expression of a novel adipose specific collagen-like factor,apM1 (adiposemost abundant gene transcript 1)[J].Biochem Biophys Res Commun,1996,221:286.
  • 5Berg A H,Combs T P,Scherer P E,et al.ACRP30/adiponectin:an adipokine regulating glucose and lipid metabolish[J].J TRENDS in Endocrin & Meta,2002,13:84.
  • 6Berg AH,Combs TP,Scherer PE,et al.The adipocyte-secreted protein Acrp30 enhanceshepatic insulin action[J].Nat Med,2001,7:947.
  • 7Yamauchi T,Kamon J,Kadowaki T,et al.The fat-derived hormone adiponectin reverses insulin resist-ance associated with both lipoatrophy and obesity[J].Nat Med,2001,7:947.
  • 8Tomas E,Tsao T S,Ruderman N B,et al.Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain:Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation[J].PNAS,2002,99 (25):16309.
  • 9Fruebis J,Tsao T S,Lodish H F,et al.Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice[J].PNAS,2001,98(4):2005.
  • 10Hattrori Y,Suzuki M,Kasai K,et al.Globular adiponectin upregulates nitric oxide production in vascular endothelial cells[J].Diabetologia,2003,46:1543.

共引文献102

同被引文献14

  • 1Estruch J J, Warren G W, Mullins M A, et al. Vip3A, a novel Bacillus thuringiensis vegetative insecticidal protein with a wide spectrum of activities against lepidopteran insects. Proc Natl Acad Sci USA, 1996, 93(11) : 5389-5394.
  • 2Ferre J J, Rien J. Biochemistry and genetic of insect resistance toBacillus thuringiensis. Annum Review of Entomology, 2002, 47 : 501-533.
  • 3Tabashnik B E, Caeelere Y, Dennehyet T S, et al. Insect resistance to transgenic Bt crops: lessons from the laboratory and field. Journal Economic Entmnology, 2003, 96:1031-1038.
  • 4Sharma H, Sharma K, Crouch J. Genetic transformation of crops for insect resisitance: potential and limitation. Critical Review in Plant Science, 2004, 23:47-72.
  • 5Fang J, Xu X, Wang P, et al. Characterization of chimeric Bacillus thuringiensis Vip3 toxins. Applied and Environmental Microbiology, 2007, 73:956-961.
  • 6Cheng X, Sardan R, Kaplan H, et al. Agrobactriumtransformed rice plants expressing synthetic Cryl A(b) and Cry1 A(c) genes are higly toxic to striped stem borer and yellow stem borer. Proc Natl Acad Sci USA, 1998, 95:2767-2772.
  • 7Anderson H M, Allen J R, Groat J R, et al. Corn plant and seed corresponding to transgenic event MON89034 and methods for detection and use thereof. United States Patent Application 2008, 0260932 A1.
  • 8Gahan L, Ma Y, Coble M, et 81. Genetic basis of resistance to CrylAc and Cry2Aa in Heliothis virescens. Journal of Economic Entomology, 2005, 98 : 1357-1368.
  • 9Estrueh J, Yu C G, Warren G W,et al. Class of proteins for the control of plant pests. United States Patent, 5,877,012. 1999.
  • 10Kurtz R W, McCaffery A, O' Reilly D. Insect resistance management for Syngenta' s VipCot^TM transgenic cotton. J Invertebr Patho1,2007, 95 ( 3 ) : 227- 230.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部